Skip to main content
BridgeBio Pharma, Inc. (FRA:2CL)
Germany flag Germany · Delayed Price · Currency is EUR
63.44
+0.84 (1.34%)
At close: Dec 5, 2025

BridgeBio Pharma Revenue

BridgeBio Pharma had revenue of $120.70M USD in the quarter ending September 30, 2025, with 4,318.01% growth. This brings the company's revenue in the last twelve months to $353.78M, up 62.46% year-over-year. In the year 2024, BridgeBio Pharma had annual revenue of $221.90M with 2,285.27% growth.

Revenue (ttm)
$353.78M
Revenue Growth
+62.46%
P/S Ratio
40.46
Revenue / Employee
$484.63K
Employees
730
Market Cap
12.20B EUR

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024221.90M212.60M2,285.27%
Dec 31, 20239.30M-68.35M-88.02%
Dec 31, 202277.65M7.93M11.38%
Dec 31, 202169.72M61.47M745.14%
Dec 31, 20208.25M-32.31M-79.66%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SAP SE 36.49B
Siemens Aktiengesellschaft 78.91B
Allianz SE 105.02B
Deutsche Telekom AG 121.02B
Siemens Energy AG 39.08B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München 62.10B
Rheinmetall AG 11.00B
Deutsche Bank Aktiengesellschaft 29.86B
Revenue Rankings

BridgeBio Pharma News

More News